Clinical Trial Update: The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 clinical trial investigating the role of miR-30 family dysregulation in response to antipsychotic treatment for schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Shanxi Medical University | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: UNKNOWN